• Science & Technology

Can cancer cells communicate?

Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too. Cancer cells use electricity to help them spread. A new study shows it might be key to controlling their other behaviours, too.

28 February 2023

• Science & Technology

The ecDNA story – catching the mastermind behind cancer evolution

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

20 February 2023

• For Researchers

A real Eureka moment for translation

We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily. We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily.

10 February 2023

• Policy & Insight
• Health & Medicine

World Cancer Day 2023: where does the UK stand?

Ahead of World Cancer Day 2023, a new report from Cancer Research UK shows that the impact of cancer for people in the UK is only set to grow. Ahead of World Cancer Day 2023, a new report from Cancer Research UK shows that the impact of cancer for people in the UK is only set to grow.

3 February 2023

• For Researchers

Hacking cancer cell metabolism

Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments. Restricting cancer cells of specific amino acids can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets which can enhance cancer treatments.

30 January 2023

• Health & Medicine

Chemo before surgery helps stop colon cancer coming back

Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded. Giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back, according to a trial we funded.

20 January 2023

• Health & Medicine

Women in science: Cancer research pioneers – part 1

As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we're celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

18 January 2023

• Health & Medicine

Early cancer diagnosis and COVID-19: unpicking the impact of the pandemic

Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future? Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future?

20 December 2022

• Health & Medicine

20 years on: how we've decreased cancer death rates

Overall, cancer death rates have decreased by 16% in the UK since we were founded. For our 20th anniversary, we're looking back at the influence and involvement we've had in reducing cancer death rates. Overall, cancer death rates have decreased by 16% in the UK since we were founded. For our 20th anniversary, we're looking back at the influence and involvement we've had in reducing cancer death rates.

17 December 2022

• For Researchers

The power of partnership – the unique alliance taking on brain cancer

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

15 December 2022

• For Supporters

The Taylor Family Foundation gives £2.1m to support head and neck cancer research

12 December 2022

• Health & Medicine
• Policy & Insight

The 10-year cancer plan: is improving cancer survival still a priority for this Government?  

Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer. Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer.

8 December 2022